{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:59:14Z","timestamp":1788872354078,"version":"build-2803163510"},"reference-count":124,"publisher":"Informa UK Limited","issue":"8","funder":[{"name":"Montana NSF EPSCOR","award":["ESP-0701906"],"award-info":[{"award-number":["ESP-0701906"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.4155\/fmc.14.46","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T06:41:49Z","timestamp":1403678509000},"page":"923-943","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["4-Isoxazolyl-1,4-Dihydropyridines: A Tale of Two Scaffolds"],"prefix":"10.1080","volume":"6","author":[{"given":"Nicholas R","family":"Natale","sequence":"first","affiliation":[{"name":"Medicinal Chemistry Graduate Program, Department of Biomedical &amp; Pharmaceutical Sciences, The University of Montana, Missoula MT59812, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A","family":"Steiger","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Graduate Program, Department of Biomedical &amp; Pharmaceutical Sciences, The University of Montana, Missoula MT59812, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,6,25]]},"reference":[{"key":"e_1_3_3_3_1","volume-title":"Organic Chemistry of Drug Design and Drug Action (Second Edition).","author":"Silverman RB","year":"2004","unstructured":"Silverman RB , Organic Chemistry of Drug Design and Drug Action (Second Edition).Academic Press, NY, USA (2004)."},{"key":"e_1_3_3_4_1","volume-title":"Bioisosteres in Medicinal Chemistry, Methods and Principles in Medicinal Chemistry (Volume 54).","author":"Brown N","year":"2012","unstructured":"Brown N . Bioisosteres in Medicinal Chemistry, Methods and Principles in Medicinal Chemistry (Volume 54).Wiley-VCH, Weinheim, Germany (2012)."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00120a002"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm9602928"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm9903996"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btn479"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm000164q"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.2174\/1386207013330896"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/9783527665143"},{"issue":"3","key":"e_1_3_3_13_1","first-page":"2172","article-title":"Scaffold hopping","volume":"1","author":"Boehm H-J","year":"2004","unstructured":"Boehm H-J . Scaffold hopping. Drug Discov. Today Technol.1 (3), 2172\u201324 (2004).","journal-title":"Drug Discov. Today Technol."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2010.02.018"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023632419813"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1838(00)00128-4"},{"key":"e_1_3_3_17_1","first-page":"301","article-title":"Recent applications of isoxazole ring in medicinal chemistry","volume":"3","author":"Pevarello P","year":"1999","unstructured":"Pevarello P , AmiciR, BrascaMG, VillaM, VarasiM. Recent applications of isoxazole ring in medicinal chemistry. Targets Heterocycl. Syst.3, 301 (1999).","journal-title":"Targets Heterocycl. Syst."},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/3527603948"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cber.188802101217"},{"key":"e_1_3_3_20_1","first-page":"249","article-title":"Ueber die Einwirkung des Natriums auf auf Isobuttersaureather","volume":"1","author":"Hantsch A","year":"1888","unstructured":"Hantsch A , Ueber die Einwirkung des Natriums auf auf Isobuttersaureather. Justus Liebigs Ann. Chem.1, 249 (1888).","journal-title":"Justus Liebigs Ann. Chem."},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.3762\/bjoc.7.57"},{"issue":"2","key":"e_1_3_3_22_1","first-page":"365","article-title":"Chemistry of heterocyclic compounds: isoxazoles, Part 1","volume":"49","author":"Kochetkov NK","year":"1963","unstructured":"Kochetkov NK , SokolovSD. Chemistry of heterocyclic compounds: isoxazoles, Part 1. Adv. Het. Chem.49 (2), 365 (1963).","journal-title":"Adv. Het. Chem."},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2725(08)60692-3"},{"key":"e_1_3_3_24_1","first-page":"1","volume-title":"Comprehensive Heterocyclic Chemistry.","author":"Lang SA","year":"1984","unstructured":"Lang SA , LinYI. Comprehensive Heterocyclic Chemistry.PottsKT (Ed). Pergamon Press, NY, USA, 6, 1 (1984)."},{"key":"e_1_3_3_25_1","volume-title":"Isoxazoles.","author":"Grunanger P","year":"1990","unstructured":"Grunanger P , Vita-FinziP. Isoxazoles.John Wiley and Sons Inc., NY, USA (1990)."},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.2174\/1385272054368420"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/00304949309457997"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jlac.18822150102"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr60275a001"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr00048a004"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389557033488141"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/0-387-27526-6"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.2610090203"},{"issue":"11","key":"e_1_3_3_34_1","first-page":"22","article-title":"Learning from the Hantzsch synthesis","volume":"30","author":"Natale NR","year":"2000","unstructured":"Natale NR . Learning from the Hantzsch synthesis, Chem. Innov.30 (11), 22\u201328 (2000).","journal-title":"Chem. Innov."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(89)90393-6"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc706"},{"key":"e_1_3_3_37_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-60761-416-6_4","volume-title":"Multi-Drug Resistance in Cancer.","author":"Gillet JP","year":"2010","unstructured":"Gillet JP , GottesmanM. Mechanisms of multi-drug resistance in cancer. In: Multi-Drug Resistance in Cancer.ZhouJ (Ed.). Humana Press,, NY, USA, 47\u201376 (2010)."},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/00397918308063716"},{"key":"e_1_3_3_39_1","first-page":"323","article-title":"Synthesis and antitubercular activity of N3, N5-diaryl14--(5-arylisoxazol-3-yl)-1,4-dihydropyridine-3,5-dicarboxamide","volume":"19","author":"Shafu B","year":"2008","unstructured":"Shafu B , AminiM, AkbarzadehT, ShafieeA. Synthesis and antitubercular activity of N3, N5-diaryl14--(5-arylisoxazol-3-yl)-1,4-dihydropyridine-3,5-dicarboxamide. J. Sci. I. R. Iran19, 323\u2013328 (2008).","journal-title":"J. Sci. I. R. Iran"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03245800"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1107\/S0108270186094180"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.5570240541"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00397a035"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2797(90)90022-F"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00170a032"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1021\/jo00049a039"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4039(00)77500-9"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-458X(199607)34:7<495::AID-OMR899>3.0.CO;2-5"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm980439q"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0040-4039(84)80036-2"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1021\/jo00350a047"},{"key":"e_1_3_3_52_1","first-page":"4011","article-title":"Synthesis, metalation and electrophilic quenching of alkyl-isoxazole-4-tertiary carboxamides. A critical comparison of three isoxazole lateral metalation methods","volume":"24","author":"Niou CS","year":"1986","unstructured":"Niou CS , NataleNR. Synthesis, metalation and electrophilic quenching of alkyl-isoxazole-4-tertiary carboxamides. A critical comparison of three isoxazole lateral metalation methods. Heterocycles24, 4011\u20134012 (1986).","journal-title":"Heterocycles"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.5570240522"},{"key":"e_1_3_3_54_1","first-page":"1680","article-title":"3-(1,3-diphenylpropan-2-yl)-4-methyl-6-phenylisoxazolo[3,4-d]pyridazin-7(6H)-one","volume":"69","author":"Campana C","year":"2013","unstructured":"Campana C , MirzaeiJ, KoernerC, GatesC, NataleNR. 3-(1,3-diphenylpropan-2-yl)-4-methyl-6-phenylisoxazolo[3,4-d]pyridazin-7(6H)-one. Acta Cryst.E69, 1680\u20131681 (2013).","journal-title":"Acta Cryst."},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm020354w"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2012.09.022"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.11.068"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/00304940309355833"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.5570230347"},{"key":"e_1_3_3_60_1","unstructured":"Baldwin J HalczenkoW HartmanG PhilipsB. US4735956A (1988)."},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201100258"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.56.5.676"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1021\/jo00284a036"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejoc.201101823"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1021\/jo050163b"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja0471525"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci060094h"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198309000-00020"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00119a009"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.10124"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.27.040187.002023"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2007.09.002"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1039\/c39860000739"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2004.03.063"},{"issue":"2","key":"e_1_3_3_75_1","first-page":"1071","article-title":"A new type of Ca-channel modulation by a novel class of 1,4 dihydropyridines","volume":"60","author":"Bechem M","year":"1997","unstructured":"Bechem M , GoldmannS, GrossRet al. A new type of Ca-channel modulation by a novel class of 1,4 dihydropyridines. Life Sci.60 (2), 1071\u20131078 (1997).","journal-title":"Life Sci."},{"issue":"3","key":"e_1_3_3_76_1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0026-895X(25)08953-9","article-title":"Pharmacologic and radioligand binding studies of 1,4-dihydropyridines in rat cardiac and vascular preparations: stereoselectivity and voltage dependence of antagonist and activator interactions","volume":"41","author":"Zheng W","year":"1992","unstructured":"Zheng W , StoltefussJ, GoldmannS, TriggleJ. Pharmacologic and radioligand binding studies of 1,4-dihydropyridines in rat cardiac and vascular preparations: stereoselectivity and voltage dependence of antagonist and activator interactions. Mol. Pharmacol.41 (3), 535\u2013541 (1992).","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00465-7"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1986.tb04565.x"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00096a005"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.199115591"},{"key":"e_1_3_3_81_1","first-page":"3095","article-title":"Drug action and cellular calcium regulation","volume":"16","author":"Janis RA","year":"1987","unstructured":"Janis RA , SilverPJ, TriggleDJ. Drug action and cellular calcium regulation. Adv. Drug Res.16, 3095\u20133091 (1987).","journal-title":"Adv. Drug Res."},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00360a001"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00400a008"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.198403011"},{"key":"e_1_3_3_85_1","first-page":"221","article-title":"Determination of the conformation of felodipine by 1H NMR spin lattice relaxation time measurements","volume":"18","author":"Berntsson P","year":"1981","unstructured":"Berntsson P , CarterR.E. Determination of the conformation of felodipine by 1H NMR spin lattice relaxation time measurements. Acta Pharmaceutica Suec.18, 221\u2013226 (1981).","journal-title":"Acta Pharmaceutica Suec."},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00387a019"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm061245a"},{"issue":"19","key":"e_1_3_3_88_1","first-page":"2905","article-title":"Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin","volume":"31","author":"Tsuruo T","year":"1983","unstructured":"Tsuruo T , LidaH, YamashiroM, TsukagoshiS, SakuraiY. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin. Cancer Res.31 (19), 2905\u20132910 (1983).","journal-title":"Cancer Res."},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.1.17"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(92)90149-D"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-827X(02)01229-6"},{"issue":"4","key":"e_1_3_3_92_1","first-page":"328","article-title":"Effects of R-enantiomer(GR66234A) and L-enantiomer (GR66235A) of telupidine, a newer dihydropyridine derivative, on cell line displaying the multidrug resistant phenotype","volume":"79","author":"Tolomeo M","year":"1994","unstructured":"Tolomeo M , GancitanoR, MussoMet al. Effects of R-enantiomer(GR66234A) and L-enantiomer (GR66235A) of telupidine, a newer dihydropyridine derivative, on cell line displaying the multidrug resistant phenotype. Haematologica79 (4), 328\u2013333 (1994).","journal-title":"Haematologica"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(00)00651-X"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-007-9026-x"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.02.001"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2007.00569.x"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2007.09.002"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20406"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.003558"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.002089"},{"issue":"1","key":"e_1_3_3_101_1","first-page":"484","article-title":"Voltage-dependent inactivation of voltage gated calcium channels","volume":"90","author":"Mary A","year":"2005","unstructured":"Mary A , ZamponiG. Voltage-dependent inactivation of voltage gated calcium channels. Landes Biosci.90 (1), 484\u2013486 (2005).","journal-title":"Landes Biosci."},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.07.025"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1007\/7081_2007_095"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-005-8112-0"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.2174\/138945006777709593"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(98)92023-7"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.61.6.1366"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(98)92024-9"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00649-4"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)84855-X"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(92)92404-L"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi973045u"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/0925-4439(96)00008-7"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1997.00130.x"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.1999.00098.x"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.11.2503"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.58.3.624"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm3003697"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr200060g"},{"key":"e_1_3_3_120_1","volume-title":"Foye's Principles of Medicinal Chemistry (Seventh Edition).","author":"Lemke TL","year":"2013","unstructured":"Lemke TL , WilliamsDA, RocheVF, ZitoSW. Foye's Principles of Medicinal Chemistry (Seventh Edition).Lippincott Wiliiams and Wilkins, NY, USA (2013)."},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1021\/ml400074k"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00403a002"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi035965k"},{"key":"e_1_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja206867t"},{"key":"e_1_3_3_125_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.050492"},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi0608109"}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc.14.46","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T09:10:45Z","timestamp":1746263445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc.14.46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":124,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.4155\/fmc.14.46"],"URL":"https:\/\/doi.org\/10.4155\/fmc.14.46","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"value":"1756-8919","type":"print"},{"value":"1756-8927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-06-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}